Eliteimmune And Integrated Biotherapeutics Enter Into Collaborative Research To Combat Methicillin-Resistant Staphylococcus Aureus (MRSA).

Eliteimmune will continue to develop Pan-Ebolavirus antibody CA45, previously shown to fully protect non-human primates against live virus challenge.

Eliteimmune signed the lease with Scheer Partners to move into their newly renovated next generation lab facility located at 704 Quince Orchard Road in th...